Mefloquine Inhibits Esophageal Squamous Cell Carcinoma Tumor Growth by Inducing Mitochondrial Autophagy

Esophageal squamous cell carcinoma (ESCC) has a worldwide impact on human health, due to its high incidence and mortality. Therefore, identifying compounds to increase patients' survival rate is urgently needed. Mefloquine (MQ) is an FDA-approved anti-malarial drug, which has been reported to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Yifei, Zhang, Jing, Lu, Bingbing, Bao, Zhuo, Zhao, Jimin, Lu, Xianyu, Wei, Yaxing, Yao, Ke, Jiang, Yanan, Yuan, Qiang, Zhang, Xiaofan, Li, Bo, Chen, Xinhuan, Dong, Zigang, Liu, Kangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400730/
https://www.ncbi.nlm.nih.gov/pubmed/32850358
http://dx.doi.org/10.3389/fonc.2020.01217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400730/
https://www.ncbi.nlm.nih.gov/pubmed/32850358
http://dx.doi.org/10.3389/fonc.2020.01217

Ejemplares similares